NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/05/2026
Back to search
Official data from USPTO
REGENERATIVE TRIFECTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REGENERATIVE TRIFECTA
ST13
US500000099039941Class
5, 44
Filing
99039941
Registration
8238405
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
05/05/2026
Trademark type
Word
Nice classes
5, 44
Filing date
02/13/2025
Registration date
05/05/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2026
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/15/2025
First use in commerce
01/15/2025
Drawing code
4
Owner type
16
Owner location
Cave Creek, AZ, US
Examiner
PATEL, SHEENA KAPOOR
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
R3 Stem Cell, LLC
Representatives
Marc Cullen Goldsen Davis Miles, PLLC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for use in cell cultures for medical purposes; Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Stem cells for medical purposes; Biological preparations for the treatment of chronic musculoskeletal pain; Biologics in the nature of pharmaceutical preparations for the treatment of chronic musculoskeletal pain
Class 44
Health care; Medical services; Medical services in the field of treatment of chronic pain; Medical services relating to the removaltreatment and processing of stem cells; Providing medical information; Regenerative medicine services; Stem cell therapy services
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2026
PUBO
PUBLISHED FOR OPPOSITION
03/17/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/24/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2025
GNRT
NON-FINAL ACTION E-MAILED
09/26/2025
CNRT
NON-FINAL ACTION WRITTEN
09/26/2025
DOCK
ASSIGNED TO EXAMINER
07/21/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/13/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/13/2025
NWAP
NEW APPLICATION ENTERED
02/13/2025
Continuous trademark protection
Get notified about every new filing that threatens REGENERATIVE TRIFECTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.